Hydralazine Hydrochloride Injection
Product Images NDC 63323-614
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 63323-614). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Hydra-label-01.jpg (Hydra Label 01)
This is a description of a medication labeled as Hydralazine Hydrochloride Injection, USP, containing 20 mg per mL. It is indicated for intramuscular or intravenous use only and comes in 25 x 1mL single-dose vials. The contents of each mL include Hydralazine hydrochloride, propylene glycol, methylparaben, propylparaben, and water for injection. It is sterile, nonpyrogenic, and should be stored at 20° to 25°C. The pH of the solution is stated to be 3.4 to 4.4 and can be adjusted with hydrochloric acid and/or sodium hydroxide. This medication is meant for emergency use in patients who are unable to take oral medication. The package insert should be consulted for the usual dosage information, and any unused portion should be discarded to heed the warning provided. The container closure is latex-free.*
Hydra-label-02.jpg (Hydra Label 02)
Hydra-struc-01.jpg (Hydra Struc 01)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.